Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW, Myrmel H. Nystad TW, et al. Among authors: myrmel h. J Clin Virol. 2007 Apr;38(4):292-7. doi: 10.1016/j.jcv.2007.01.006. Epub 2007 Mar 1. J Clin Virol. 2007. PMID: 17336144
Raised levels of antibodies to human viruses at the clinical onset of autoimmune chronic active hepatitis.
Kalvenes MB, Haukenes G, Nysaeter G, Kalland KH, Myrmel H. Kalvenes MB, et al. Among authors: myrmel h. J Viral Hepat. 1995;2(3):159-64. doi: 10.1111/j.1365-2893.1995.tb00023.x. J Viral Hepat. 1995. PMID: 7493312
Comparison of tests for heterophile antibodies with a test for specific IgM-antibodies to Epstein-Barr virus. Brief report.
Myrmel H. Myrmel H. APMIS. 1988 Mar;96(3):280-1. doi: 10.1111/j.1699-0463.1988.tb05302.x. APMIS. 1988. PMID: 2831918
Evaluation of a rapid test for detection of antibodies against human immunodeficiency virus (HIV).
Josefsen D, Myrmel H. Josefsen D, et al. Among authors: myrmel h. APMIS. 1989 Jan;97(1):95-6. doi: 10.1111/j.1699-0463.1989.tb00761.x. APMIS. 1989. PMID: 2914110
Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera.
Nilsen A, Ulvestad E, Marsden H, Langeland N, Myrmel H, Matre R, Haarr L. Nilsen A, et al. Among authors: myrmel h. J Virol Methods. 2003 Jan;107(1):21-7. doi: 10.1016/s0166-0934(02)00185-4. J Virol Methods. 2003. PMID: 12445934
Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
Myrmel H, Navaratnam V, Asjø B. Myrmel H, et al. J Clin Virol. 2005 Nov;34(3):211-5; discussion 216-8. doi: 10.1016/j.jcv.2005.05.013. Epub 2005 Aug 19. J Clin Virol. 2005. PMID: 16112611
The hepatitis C virus enigma.
Myrmel H, Ulvestad E, Asjø B. Myrmel H, et al. APMIS. 2009 May;117(5-6):427-39. doi: 10.1111/j.1600-0463.2009.02454.x. APMIS. 2009. PMID: 19400866 Review.
Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors.
Melve GK, Myrmel H, Eide GE, Hervig T. Melve GK, et al. Among authors: myrmel h. Transfusion. 2009 Nov;49(11):2359-65. doi: 10.1111/j.1537-2995.2009.02320.x. Epub 2009 Aug 21. Transfusion. 2009. PMID: 19702654
[A man with viral myocarditis].
Oma DH, Fanebust R, Nordbø SA, Myrmel H. Oma DH, et al. Among authors: myrmel h. Tidsskr Nor Laegeforen. 2007 Nov 1;127(21):2814-6. Tidsskr Nor Laegeforen. 2007. PMID: 18046788 Norwegian. No abstract available.
Epstein-Barr virus reactivation and multiple sclerosis.
Torkildsen Ø, Nyland H, Myrmel H, Myhr KM. Torkildsen Ø, et al. Among authors: myrmel h. Eur J Neurol. 2008 Jan;15(1):106-8. doi: 10.1111/j.1468-1331.2007.02009.x. Epub 2007 Nov 27. Eur J Neurol. 2008. PMID: 18042233
38 results
Jump to page
Feedback